Asarina Pharma AB (publ) (ASAP: FN Stockholm) tillkännagav idag att FDA har godkänt bolagets IND-ansökan för sin ledande läkemedelskandidat Sepranolone i menstruell migrän. Godkännandet är… Read More »Sepranolone får IND-godkännande från FDA i menstruell migrän
Stockholm, June 12 2019: A new paper in the Journal of Neuroendocrinology shows how Asarina Pharma’s compound Sepranolone reduced tics in an animal model of… Read More »Asarina Pharma: Journal of Neuroendocrinology publishes preclinical data on effective Tourette syndrome therapy with no side effects
Stockholm, June 11, 2019: Premenstrual dysphoric disorder (PMDD) has been given its own classification code and for the first time classified clearly as a gynaecological,… Read More »Premenstrual Dysphoric Disorder recognized in new WHO International Classification of Diseases ICD-11
(Stockholm, June 4, 2019) Asarina Pharma AB (publ) today announces that it will, pursuant to the authorisation granted by the Annual General Meeting on 8… Read More »Asarina Pharma issues new shares to Ergomed plc
(Stockholm, 4 juni 2019) Asarina Pharma meddelar idag att de, enligt det bemyndigande som bolagsstämman den 8 maj 2019 beviljat, utfärdar 246 434 nya aktier… Read More »Asarina Pharma AB (publ) utfärdar nya aktier till Ergomed plc
(Stockholm May 8, 2019) On 8 May 2019, the Annual General Meeting (”AGM”) of Asarina Pharma AB (publ) was held in Stockholm. Read below for… Read More »Decisions from Annual General Meeting of Asarina Pharma, 8 May 2019
Asarina Pharma AB (publ) avhöll den 8 maj 2019 sin årsstämma i Stockholm. Stämman fattade bland annat följande beslut. Utdelning Stämman beslutade att ingen utdelning… Read More »Asarina Pharma: Beslut vid årsstämman den 8 maj 2019
Asarina Pharma AB (publ) avhöll den 8 maj 2019 sin årsstämma i Stockholm. Stämman fattade bland annat följande beslut. Utdelning Stämman beslutade att ingen utdelning… Read More »Asarina Pharma: Beslut vid årsstämman den 8 maj 2019
(Stockholm May 8, 2019) On 8 May 2019, the Annual General Meeting (”AGM”) of Asarina Pharma AB (publ) was held in Stockholm. Read below for… Read More »Decisions from Annual General Meeting of Asarina Pharma, 8 May 2019
(April 11 2019) The following proposals (items 12-15 in the agenda) for the upcoming Annual General Meeting have been made: – Number of directors: six… Read More »Asarina Pharma Proposals regarding the Board of Directors for the Annual General Meeting 2019